findmyKOL

Nikolaos Stathatos, MD

Basic profile

Massachusetts General Hospital

ORCIDNone on fileNPI
RegionBoston, MA · NortheastSpecialtyEndocrinology, Diabetes & MetabolismFocusEndocrinology/Metabolic
ActivityNot yet indexedfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Nikolaos Stathatos is an Endocrinology/Metabolic physician affiliated with Massachusetts General Hospital. OpenAlex indexes 31 publications with 751 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
31publications

Distinct works indexed by OpenAlex.

751citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Hormonal (systemic)

    92.2%
    l-Thyroxine78.6%
    Levothyroxine Sodium79%Synthroid17%Tirosint3%Levoxyl1%
    Part D<11 patients
    Thyroid Hormone Synthesis Inhibitor10.6%
    Methimazole100%
    Part D36 patients

    + 1 more class in this area

  • Sensory organs

    3.8%
    Corticosteroid3.8%
    Dexamethasone59%Hydrocortisone41%
    Part D<11 patients
  • Metabolism & gastrointestinal

    2.9%
    Vitamin D3 Analog1.9%
    Calcitriol100%
    Part D<11 patients
    Corticosteroid1.1%
    Prednisone100%
    Part D<11 patients
Where care is delivered (Part B)6.5% facility · 93.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”